BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17692907)

  • 1. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment.
    Zhou XC; Dowdy SC; Podratz KC; Jiang SW
    Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetics of ovarian cancer drug resistance and resensitization.
    Balch C; Huang TH; Brown R; Nephew KP
    Am J Obstet Gynecol; 2004 Nov; 191(5):1552-72. PubMed ID: 15547525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells.
    Ren Y; Liu X; Ma D; Feng Y; Zhong N
    Cancer Genet Cytogenet; 2007 Jun; 175(2):107-16. PubMed ID: 17556066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of epigenetics in urological cancers.
    Ramachandran K; Soloway MS; Singal R; Manoharan M
    Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics, disease, and therapeutic interventions.
    Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
    Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation: a new research area for melatonin?
    Korkmaz A; Reiter RJ
    J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypermethylation as a chemotherapy target.
    Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
    Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in human disease and prospects for epigenetic therapy.
    Egger G; Liang G; Aparicio A; Jones PA
    Nature; 2004 May; 429(6990):457-63. PubMed ID: 15164071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
    Fleury L; Gerus M; Lavigne AC; Richard-Foy H; Bystricky K
    Oncogene; 2008 Jul; 27(29):4075-85. PubMed ID: 18317449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
    Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
    Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.